Targeted therapies for unresectable stage III non-small cell lung cancer
Author(s) -
Jordi Remón,
Lizza E.L. Hendriks
Publication year - 2021
Publication title -
mediastinum
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2522-6711
DOI - 10.21037/med-21-8
Subject(s) - anaplastic lymphoma kinase , medicine , oncology , lung cancer , population , epidermal growth factor receptor , adverse effect , chemoradiotherapy , tyrosine kinase , cancer , receptor , environmental health , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom